These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 14759551)

  • 1. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural regulation of glucagon-like peptide-1 secretion in pigs.
    Hansen L; Lampert S; Mineo H; Holst JJ
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E939-47. PubMed ID: 15475512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
    Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1010-8. PubMed ID: 10827002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do we know about the secretion and degradation of incretin hormones?
    Deacon CF
    Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
    Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
    Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB; Buchan AM; Kofod H
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiological role of GLP-1 in human: incretin, ileal brake or more?
    Schirra J; Göke B
    Regul Pept; 2005 Jun; 128(2):109-15. PubMed ID: 15780430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.
    Brubaker PL; Anini Y
    Can J Physiol Pharmacol; 2003 Nov; 81(11):1005-12. PubMed ID: 14719035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach.
    Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V
    Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes.
    D'Alessio DA; Vahl TP
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E882-90. PubMed ID: 15140755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the physiology of GIP and GLP-1.
    Holst JJ
    Horm Metab Res; 2004; 36(11-12):747-54. PubMed ID: 15655703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum.
    Dumoulin V; Moro F; Barcelo A; Dakka T; Cuber JC
    Endocrinology; 1998 Sep; 139(9):3780-6. PubMed ID: 9724030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness.
    Delmeire D; Flamez D; Moens K; Hinke SA; Van Schravendijk C; Pipeleers D; Schuit F
    Biochem Pharmacol; 2004 Jul; 68(1):33-9. PubMed ID: 15183115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
    Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
    Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient, neural and endocrine control of glucagon-like peptide secretion.
    Dubé PE; Brubaker PL
    Horm Metab Res; 2004; 36(11-12):755-60. PubMed ID: 15655704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.